Viewing Study NCT05405894


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2026-04-24 @ 2:04 PM
Study NCT ID: NCT05405894
Status: UNKNOWN
Last Update Posted: 2024-05-14
First Post: 2022-05-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Zoledronic Acid to Prevent Bone Loss Following Denosumab Discontinuation
Sponsor: University of Calgary
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Osteoporosis View
None Osteoporosis, Postmenopausal View
None Osteopenia View
None Bone Loss View
Keywords: